This is the authors' abstract. We don't add key points for this paper.
Mid-infrared lasers at 3 μm hold many important applications in biological tissue ablation, gas detection, and so on. At present, holmium ion (Ho 3+ ) can achieve efficient laser oscillation at this wavelength by the 5 I 6 → 5 I 7 transition. However, in the traditional high-phonon-energy oxide crystals ( e.g. , YAG), it is quite difficult to realize ∼3 μm continuous-wave (CW) lasing owing to the strong non-radiative relaxation and inherent self-terminating effect. Here, for the first time, we investigated the growth, spectroscopy, and mid-infrared lasing properties of Ho,Pr:YGG crystal. The growth of high-quality laser crystals was achieved using the optical floating zone method. Compared to the YAG host, YGG has a reduced phonon energy, which is beneficial for decreasing the probability of non-radiative relaxation and strengthening the ∼3 μm emission intensity. Then, Pr 3+ ions were introduced as deactivators to reduce the lifetimes of 5 I 7 low-level and promote the population inversion of Ho 3+ activators. As a result, Ho,Pr:YGG yields the stable ∼3 μm CW lasing, delivering a maximum output power of 548 mW and a slope efficiency of 5.88%. As far as we are aware, this is the highest reported CW output at ∼3 μm among Ho 3+ -doped oxide-based laser crystals.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: